Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2015

Apr 28, 2015

32939_dirs_2015-04-28_3d30ff33-2895-4854-abd9-2c7e0693a96d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2015-04-24

Reporting Person: Trowbridge Stephen A (SVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-04-24 Common Stock A 15000 Acquired 40765 Direct

Footnotes

F1: The acquisition of 15,000 shares of common stock represents 15,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal installments beginning on 04/24/2016.